308 related articles for article (PubMed ID: 33968058)
21. Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation.
van Rhee F; Barrett J
Cytotherapy; 2002; 4(1):3-10. PubMed ID: 11953036
[TBL] [Abstract][Full Text] [Related]
22. Going beyond serology for stratifying the risk of CMV infection in transplant recipients.
Navarro D; Fernández-Ruiz M; Aguado JM; Sandonís V; Pérez-Romero P
Rev Med Virol; 2019 Jan; 29(1):e2017. PubMed ID: 30358016
[TBL] [Abstract][Full Text] [Related]
23. Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.
Brestrich G; Zwinger S; Roemhild A; Noutsias M; Rohde M; Keeren K; Sawitzki B; Volk HD; Reinke P; Hammer MH
J Immunother; 2009; 32(9):932-40. PubMed ID: 19816188
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of adoptive T-cell therapy in treating cytomegalovirus infections post-haematopoietic stem cell transplantation: A systematic review and meta-analysis.
Taherian MR; Azarbar P; Barkhordar M; Toufani S; Aliabadi LS; Bahri T; Ahmadvand M; Yaghmaie M; Daneshvar A; Vaezi M
Rev Med Virol; 2024 Jul; 34(4):e2558. PubMed ID: 38878003
[TBL] [Abstract][Full Text] [Related]
26. Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.
Maffini E; Giaccone L; Festuccia M; Brunello L; Busca A; Bruno B
Expert Rev Hematol; 2016 Jun; 9(6):585-96. PubMed ID: 27043241
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Clancy LE; Blyth E; Simms RM; Micklethwaite KP; Ma CK; Burgess JS; Antonenas V; Shaw PJ; Gottlieb DJ
Biol Blood Marrow Transplant; 2013 May; 19(5):725-34. PubMed ID: 23380344
[TBL] [Abstract][Full Text] [Related]
28. T-cell therapy for cytomegalovirus infection.
Mui TS; Kapp M; Einsele H; Grigoleit GU
Curr Opin Organ Transplant; 2010 Dec; 15(6):744-50. PubMed ID: 20930639
[TBL] [Abstract][Full Text] [Related]
29. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
Melendez D; Razonable RR
Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
[TBL] [Abstract][Full Text] [Related]
30. CMV-specific T cell therapy.
Einsele H; Kapp M; Grigoleit GU
Blood Cells Mol Dis; 2008; 40(1):71-5. PubMed ID: 17851094
[TBL] [Abstract][Full Text] [Related]
31. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
[TBL] [Abstract][Full Text] [Related]
32. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
Kowalsky S; Arnon R; Posada R
Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
[TBL] [Abstract][Full Text] [Related]
33. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
[TBL] [Abstract][Full Text] [Related]
34. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.
Einsele H; Roosnek E; Rufer N; Sinzger C; Riegler S; Löffler J; Grigoleit U; Moris A; Rammensee HG; Kanz L; Kleihauer A; Frank F; Jahn G; Hebart H
Blood; 2002 Jun; 99(11):3916-22. PubMed ID: 12010789
[TBL] [Abstract][Full Text] [Related]
35. Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.
Bao L; Dunham K; Stamer M; Mulieri KM; Lucas KG
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1156-1162. PubMed ID: 18804046
[TBL] [Abstract][Full Text] [Related]
36. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
37. [Immunological monitoring strategies for cytomegalovirus infection. Immune-based therapies].
Cantisán Bohórquez S; Navarro Ortega D
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():28-32. PubMed ID: 22541919
[TBL] [Abstract][Full Text] [Related]
38. Adoptive T-cell therapy with CD45RA-depleted donor in the treatment of cytomegalovirus disease in immunocompromised non-transplant patients.
Yuste JR; López-Díaz de Cerio A; Rifón J; Moreno C; Panizo M; Inogés S
Antivir Ther; 2019; 24(4):313-319. PubMed ID: 30912764
[TBL] [Abstract][Full Text] [Related]
39. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
40. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
